JPH07505392A - 新規な心臓保護剤 - Google Patents
新規な心臓保護剤Info
- Publication number
- JPH07505392A JPH07505392A JP5517451A JP51745193A JPH07505392A JP H07505392 A JPH07505392 A JP H07505392A JP 5517451 A JP5517451 A JP 5517451A JP 51745193 A JP51745193 A JP 51745193A JP H07505392 A JPH07505392 A JP H07505392A
- Authority
- JP
- Japan
- Prior art keywords
- dihydro
- tetramethyl
- methano
- compound according
- trans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Vascular Medicine (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Polyesters Or Polycarbonates (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Plural Heterocyclic Compounds (AREA)
- Paints Or Removers (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (15)
- 1.式 ▲数式、化学式、表等があります▲ 〔式中 RはH又はC1〜C4アルキル R1はC1〜C4アルキル R2はH又はC(0)R3 R3はH又はC1〜C■アルキル R4はOR又はN(R)2 R6はH、−C(0)R又はC1〜C4アルキルそしてnは0又は1である。〕 の化合物、及びその個々の異性体及び混合物及び製薬上受入れられるその塩。
- 2.化合物が式1Bからなる請求項1に記載の化合物。
- 3.化合物物が式1Aからなる請求項1に記載の化合物。
- 4.Rがメチルである請求項1に記載の化合物。
- 5.R1がメチルである請求項1に記載の化合物。
- 6.nが0である請求項1に記載の化合物。
- 7.R2がHである請求項1に記載の化合物。
- 8.R2がC(0)R3であり、R3がメチルである請求項1に記載の化合物。
- 9.請求項式1Bであり、Rがメチルであり、Rtがメチルてありnが0である 請求項1に記載の化合物。
- 10.化合物が10アンチ−(+/−)−7−アセチロキシ−2,3−ジヒトロ −10−ヒドロキシ−2,6,8,9,チトラメチル−2,5−メタノ−5H− 1,4−ベンゾジオキセビン−3−オン;メチル,トランス,シス(+/−)− 6−アセチロキシ−3,4−リヒトロ−3,4−ジヒドロキシ−2,5,7,8 −テトラメチル−21−1−ベンゾビラン−2−カルボキシレート;10−アン チ−(+/−)−2,3−ジヒドロ−7,10−ジヒドロキシ−2,6,8,9 −テトラメチル−2,5−メタノ−5H−1,4−ベンゾジオキセビン−3−オ ン; トラんす,シス−(+/−)−3,4−ジヒトロ−3,4,6−トリヒドロキシ −2,5,7,8−チトラメチル−2H−1−ベンゾビラン−2−カルボン酸; 10−ア7チ−(+)−(2S,5R,10R)−7−アセチロキシ−2,3− ジヒドロ−10−ヒドロキシ−2,6,8,9−テトラメチル−2,5−メタノ −5H1,4−ベンゾジオキセビン−3−オン;10−アンチ−(+)−(2S ,5B,10R)−2,3−ジヒトロ−7,10−ジヒドロキシ−2,6,8, 9−チトラメチル−2,5−メタノ−5H−1,4−ベンゾジオキセビン−3− オン; 10−アンチ−(−)−(2R,5S,10S)−7−アセチロキシ−2,3− ジヒドロ−10−ヒドロキシ−2,6,8,9−テトラメチル−2,5−メタノ −5H−1,4−ベンゾジオキセピン−3−オン;シスシス−(+)−(2R, 3S,4S)−3,4−ジヒドロ−3,4,6−トリヒドロキシ−2,5,7, 8−テトラメチル−2H−1−ベンゾピラン−2−カルボン酸; 10−アンチ−(−)−(2R,5S,10S)−2,3−ジヒドロ−7,10 −ジヒトロキシ−2,6,8,9,チトラメチル−2,5−メタノ−5H−1, 4−ベンゾジオキせビン−3−オン; 10−syn−(+)−(2S,5R,10S)−7−アセチロキシ−2,3− ジヒドロ−10−ヒドロキシ−2,6,8,9−テトラメチル−2,5−メタノ −5H−1,4−ベンゾジオキセビン−3−オン;トランス,トランス−(−) −2S,3R,4R)−3,4−ソヒドロ−3,4,6−トリヒドロキシ−2, 5,7,8−チトラメチル−2H−1−ベンゾビラン−2−カルボン酸; 10−syn−(+)−(2S,5R,10S)−2,3−ジヒドロ−7,10 −ジヒドロキシ−2,6,8,9−チトラメチル−2,5−メタノ−5H−1, 4−ベンゾジオキセビン−3−オン; 10−syn−(−)−(2R−5S,10R)−7−アセチロキシ−2,3− ジヒドロ−10−ヒドロキシ−2,6,8,9,チトラメチル−2,5−メタノ −5H−1,4−ベンゾジオキセビン−3−オン;メチルシス,トランス−(2 R,3R,4R)−4,6−ジアセチロキン−3,4−ジヒドロ−3−ヒドロキ シ−2,5,7,8,−テトラメチル−21−1−ベンゾビラン−2−カルボキ シレート;メチルシス,トランス−(2R,3R,4R)−6−アセチロキシ− 3,4−ジヒドロ−3,4−ジヒドロキシ−2,5,7,8,−テトラメチル− 2H−1−ベンゾビラン−2−カルボキシレート;トランス,トランス−(+) −(2R,3S,4S)−3,4−ジヒドロ−3,4,6−トリヒドロキシ−2 ,5,7,8−チトラメチル−2H−1−ベンゾビラン−2−カルボン酸; 10−syn−(−)−(2R,5S,10R)−2,3−ジヒドロ−7,10 −ジヒドロキシ−2,6,8,9−テトラメチル−2、5−メタノ−5H−1, 4−ベンゾジォキセビン−3−オン; 11−syn−(+/−)−8−アセチロキシ−2,3,4,6−テトラヒドロ −11−ヒドロキシ−2,7,9,10−テトラメチル−2,6−メタノ−1, 5−ベンゾジオキソシン−4−オン;又は トランス,シス−(+/−)−6−あセチロキシ−3,4−ジヒトロ−3,4− ジヒドロキシ−2,5,7,8−テトラメチル−2H−1−ベンゾビラン−2− 酢酸,メチルエステル てある請求項1に記載の化合物。
- 11.請求項1に記載の化合物及び製薬上受入れられる担体を含んでいる製剤組 成物。
- 12.製薬活性化合物としての用途の為のせい求項1に記載の化合物。
- 13.炎症性の腸の病気又は再灌流損傷の処置における用途の為の請求項1に記 載の化合物。
- 14.炎症性の腸の病気又は再灌流損傷の処置の為の請求項13に記載の製剤組 成物。
- 15.製薬上受人れられる担体と組合せる場合もある炎症性の腸の病気又は再灌 流損傷の処置の為の製剤組成物を製造する為の請求項1に記載の化合物の用途。 IG.式 ▲数式、化学式、表等があります▲ 〔式中 RはH又はC1〜C4アルキル R1はC1〜C4ルキル R2はH又はC(0)R3 R3はH又はC1〜C9アルキル R4はOR又はN(R)2 R5はH、−C(O)R又はCl〜C4アルキルモしてnは0又は1である。〕 の化合物及びその個々の異性体及び混合物及び製薬上受人れられるその塩を製造 する方法てあって、 ▲数式、化学式、表等があります▲ の化合物を適当なヒドロキシル化剤によってジヒドロキシル化し、式 ▲数式、化学式、表等があります▲ を有するシス又はトランス化合物のいずれかを与えるか、又は4−ヒドロキシル 基が酸官能基、即ち、R4がOHを表わすときの酸官能基に対しシスであるとま は、▲数式、化学式、表等があります▲ を有するラクトンを製造することがらなる方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP92400957.4 | 1992-04-06 | ||
EP92400957 | 1992-04-06 | ||
PCT/US1993/002102 WO1993020058A1 (en) | 1992-04-06 | 1993-03-08 | Novel cardioprotective agents |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07505392A true JPH07505392A (ja) | 1995-06-15 |
JP3248183B2 JP3248183B2 (ja) | 2002-01-21 |
Family
ID=8211647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51745193A Expired - Fee Related JP3248183B2 (ja) | 1992-04-06 | 1993-03-08 | 新規な心臓保護剤 |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0635010B1 (ja) |
JP (1) | JP3248183B2 (ja) |
KR (1) | KR100243820B1 (ja) |
AT (1) | ATE146175T1 (ja) |
AU (1) | AU667889B2 (ja) |
CA (1) | CA2132745C (ja) |
DE (1) | DE69306559T2 (ja) |
DK (1) | DK0635010T3 (ja) |
ES (1) | ES2098030T3 (ja) |
FI (1) | FI112658B (ja) |
GR (1) | GR3022471T3 (ja) |
HU (1) | HU217426B (ja) |
IL (1) | IL105320A (ja) |
NO (1) | NO307088B1 (ja) |
NZ (1) | NZ251131A (ja) |
TW (1) | TW232014B (ja) |
WO (1) | WO1993020058A1 (ja) |
ZA (1) | ZA932326B (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5721233A (en) * | 1992-04-06 | 1998-02-24 | Merrell Pharmaceuticals Inc. | Derivatives of 2,3-dihydro benzofuranols |
US5545660A (en) * | 1992-04-07 | 1996-08-13 | Merrell Pharmaceuticals Inc. | Hydrazide derivatives of 3,4-dihydro-2H-1-benzopyrans |
US5451603A (en) * | 1993-03-11 | 1995-09-19 | Zymogenetics, Inc. | 3,4-diarylchromans for treatment of dermatitis |
US5416098A (en) * | 1993-12-30 | 1995-05-16 | Zymogenetics, Inc. | Method for treating dermatitis and related conditions |
CN115073413B (zh) * | 2022-05-17 | 2023-06-02 | 中山大学 | 一种苯并环醚类倍半萜类化合物及其制备方法与应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3947473A (en) * | 1972-12-22 | 1976-03-30 | Hoffman-La Roche Inc. | Antioxidant chroman compounds |
CA2002649C (en) * | 1988-11-14 | 2000-06-06 | Margaret Petty | Cardioprotective tocopherol analogs |
-
1993
- 1993-03-08 AU AU37972/93A patent/AU667889B2/en not_active Ceased
- 1993-03-08 HU HU9402863A patent/HU217426B/hu not_active IP Right Cessation
- 1993-03-08 KR KR1019940703514A patent/KR100243820B1/ko not_active IP Right Cessation
- 1993-03-08 EP EP93907332A patent/EP0635010B1/en not_active Expired - Lifetime
- 1993-03-08 DK DK93907332.6T patent/DK0635010T3/da active
- 1993-03-08 DE DE69306559T patent/DE69306559T2/de not_active Expired - Lifetime
- 1993-03-08 AT AT93907332T patent/ATE146175T1/de not_active IP Right Cessation
- 1993-03-08 JP JP51745193A patent/JP3248183B2/ja not_active Expired - Fee Related
- 1993-03-08 NZ NZ251131A patent/NZ251131A/en unknown
- 1993-03-08 ES ES93907332T patent/ES2098030T3/es not_active Expired - Lifetime
- 1993-03-08 WO PCT/US1993/002102 patent/WO1993020058A1/en active IP Right Grant
- 1993-03-08 CA CA002132745A patent/CA2132745C/en not_active Expired - Lifetime
- 1993-03-31 ZA ZA932326A patent/ZA932326B/xx unknown
- 1993-04-01 TW TW082102447A patent/TW232014B/zh active
- 1993-04-05 IL IL105320A patent/IL105320A/en not_active IP Right Cessation
-
1994
- 1994-10-05 NO NO943727A patent/NO307088B1/no unknown
- 1994-10-05 FI FI944656A patent/FI112658B/fi not_active IP Right Cessation
-
1997
- 1997-02-05 GR GR960403605T patent/GR3022471T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
NZ251131A (en) | 1996-01-26 |
JP3248183B2 (ja) | 2002-01-21 |
HUT68982A (en) | 1995-08-28 |
NO307088B1 (no) | 2000-02-07 |
AU3797293A (en) | 1993-11-08 |
FI944656A (fi) | 1994-10-05 |
HU9402863D0 (en) | 1995-01-30 |
DE69306559D1 (de) | 1997-01-23 |
WO1993020058A1 (en) | 1993-10-14 |
IL105320A0 (en) | 1993-08-18 |
CA2132745A1 (en) | 1993-10-14 |
ES2098030T3 (es) | 1997-04-16 |
NO943727L (no) | 1994-12-05 |
DE69306559T2 (de) | 1997-04-10 |
EP0635010B1 (en) | 1996-12-11 |
AU667889B2 (en) | 1996-04-18 |
NO943727D0 (no) | 1994-10-05 |
ZA932326B (en) | 1993-10-18 |
GR3022471T3 (en) | 1997-05-31 |
KR100243820B1 (ko) | 2000-03-02 |
FI944656A0 (fi) | 1994-10-05 |
KR950700896A (ko) | 1995-02-20 |
FI112658B (fi) | 2003-12-31 |
EP0635010A1 (en) | 1995-01-25 |
DK0635010T3 (da) | 1996-12-30 |
CA2132745C (en) | 2000-03-21 |
HU217426B (hu) | 2000-01-28 |
ATE146175T1 (de) | 1996-12-15 |
TW232014B (ja) | 1994-10-11 |
IL105320A (en) | 1998-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2007255176B2 (en) | Use of coumarin derivatives in antifungal therapy | |
CA2329626A1 (en) | Cannabinoids as antioxidants and neuroprotectants | |
JPH07505392A (ja) | 新規な心臓保護剤 | |
JP3226185B2 (ja) | 組織保護トコフェロ−ル類似体 | |
JP3246741B2 (ja) | 2,3−ジヒドロベンゾフラノールの新規な誘導体及びその製法 | |
US5545660A (en) | Hydrazide derivatives of 3,4-dihydro-2H-1-benzopyrans | |
JP3226174B2 (ja) | 3,4−ジヒドロ−2h−1−ベンゾピラン類のヒドラジド誘導体類 | |
JPH11501655A (ja) | 2,3−ジヒドロ−ベンゾフラノール誘導体の新規な製造法 | |
US5510373A (en) | Cardioprotective agents | |
KR20090073511A (ko) | 플라보노이드 화합물을 유효성분으로 하는 말라리아 치료용약학적 조성물 | |
JP3150740B2 (ja) | ジヒドロベンゾフラン誘導体 | |
Etinger et al. | c12) United States Patent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071109 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081109 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091109 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091109 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101109 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111109 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111109 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121109 Year of fee payment: 11 |
|
LAPS | Cancellation because of no payment of annual fees |